OSTX OS Therapies Incorporated

Fundamentals / CIK 0001795091 / USD

OS Therapies Incorporated reported $8.11M in total assets and a net loss of $43.77M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open OSTX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

3 fiscal years (2023 to 2025), reported in USD.

$0$0$0-$26.88MFY 2023 Net Income: -$7.79M2023FY 2024 Net Income: -$8.88M2024FY 2025 Net Income: -$28.75M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31
Research & Development $16.36M $2.84M $3.22M
Operating Income -$28.71M -$6.81M -$4.34M
EBITDA -$28.34M -$6.81M -$4.34M
Interest Income $249 -- $2
Interest Expense -- $2.05M $3.45M
Net Income -$28.75M -$8.88M -$7.79M
Basic EPS -$0.98 -$1.28 -$1.46
Diluted EPS -$0.98 -$1.28 -$1.46
Basic Shares Outstanding -- 12.4M 5.4M
Diluted Shares Outstanding 29.3M 7.0M --

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $5.97M $6.07M $7.35M $8.80M $3.76M $2.50M $1.31M $870K
Operating Income -$9.03M -$8.58M -$10.17M -$11.99M -$6.88M -$4.84M -$5.00M -$2.97M
EBITDA -$8.91M -$8.45M -$10.04M -$11.86M -$6.75M -$4.73M -$5.00M -$2.97M
Interest Income $16K $46 $45 $54 $65 $64 $66 --
Interest Expense $621K $5.6K $75K -- -- -- -- $7.6K
Net Income -$11.28M -$8.63M -$10.40M -$13.46M -$6.88M -$4.54M -$3.88M -$2.99M
Basic EPS -$0.23 -$0.20 -$0.27 -- -$0.22 -$0.19 -$0.18 --
Diluted EPS -$0.23 -$0.20 -$0.27 -- -$0.22 -$0.19 -$0.18 --
Diluted Shares Outstanding 48.1M 43.9M 38.7M -- 32.0M 25.1M 21.2M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $270K $5.53M $39K
Cash & Short-Term Investments $270K $5.53M $39K
Total Current Assets $333K $5.53M $790K
Property, Plant & Equipment, Net $2.5K $5.3K $8.1K
Intangible Assets $6.50M -- $8.1K
Total Non-Current Assets $6.51M $5.3K $8.1K
Total Assets $6.84M $5.54M $798K
Accounts Payable $9.94M $1.66M $2.72M
Total Current Liabilities $11.76M $4.63M $24.71M
Total Non-Current Liabilities $100K $100K $100K
Total Liabilities $11.86M $4.73M $24.81M
Common Stock $37K $21K $5.3K
Retained Earnings -$67.19M -$38.43M -$29.52M
Total Stockholders' Equity -$6.10M -$3.27M -$24.02M
Total Equity -$6.10M -$3.27M -$24.02M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $432K $205K $918K $270K -- $2.80M $2.97M $5.53M
Cash & Short-Term Investments $432K $205K $918K $270K -- $2.80M $2.97M $5.53M
Total Current Assets $1.98M $3.64M $918K $333K $2.32M $3.55M $4.10M $5.53M
Property, Plant & Equipment, Net $405 $1.1K $1.8K $2.5K $3.2K $3.9K $4.6K $5.3K
Intangible Assets $6.13M $6.26M $6.38M $6.50M $6.86M $6.86M -- --
Total Non-Current Assets $6.13M $6.26M $6.38M $6.51M $6.63M $6.76M $155K $5.3K
Total Assets $8.11M $9.90M $7.30M $6.84M $8.95M $10.31M $4.25M $5.54M
Accounts Payable -- -- -- $9.94M $3.37M $2.70M $1.62M $1.66M
Total Current Liabilities $23.91M $20.64M $16.95M $11.76M $4.15M $3.46M $3.54M $4.63M
Total Non-Current Liabilities $100K $100K $100K $100K $100K $100K $100K $100K
Total Liabilities $24.01M $20.74M $17.05M $11.86M $4.25M $3.56M $3.64M $4.73M
Common Stock $47K $45K $39K $37K $33K $30K $21K $21K
Retained Earnings -$97.49M -$86.22M -$77.58M -$67.19M -$53.73M -$46.85M -$42.31M -$38.43M
Total Stockholders' Equity -$16.97M -$11.91M -$10.82M -$6.10M $3.64M $4.94M -$4.19M -$3.27M
Total Equity -$16.97M -$11.91M -$10.82M -$6.10M $3.64M $4.94M -$4.19M -$3.27M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31
Net Income -$28.75M -$8.88M -$7.79M
Depreciation & Amortization $363K $2.8K $4.2K
Stock-Based Compensation $4.27M $268K $0
Change in Payables $8.27M -$1.05M $1.35M
Operating Cash Flow -$14.24M -$7.28M -$3.01M
Capital Expenditure -$466K -- --
Free Cash Flow -$14.70M -- --
Investing Cash Flow -$466K -- $1.1K
Financing Cash Flow $9.44M $12.78M $2.87M
Net Change in Cash -$5.26M $5.50M -$132K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$11.28M -$8.63M -$10.40M -$13.46M -$6.88M -$4.54M -$3.88M -$2.99M
Depreciation & Amortization $125K $125K $125K $125K $125K $113K $695 $1.4K
Stock-Based Compensation $1.36M $1.33M $1.44M $1.60M $815K $905K $941K --
Change in Payables -- -- -- $6.56M $672K $1.09M -$46K -$110K
Operating Cash Flow -$4.65M -$5.53M -$4.56M -$3.73M -$4.71M -$2.36M -$3.44M -$2.37M
Capital Expenditure -- -- -- $0 $0 -$316K -$150K --
Free Cash Flow -- -- -- -$3.73M -$4.71M -$2.68M -$3.59M --
Investing Cash Flow -- -- -- $0 $0 -$293K -$174K --
Common Stock Issued -- -- -- -- $1.05M -- -- --
Financing Cash Flow $4.88M $4.82M $5.21M $2.12M $3.78M $2.48M $1.05M $6.05M
Net Change in Cash $227K -$713K $648K -$1.61M -$925K -$169K -$2.56M $3.68M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31
Return on Assets (ROA) -420.4% -160.4% -976.3%
Current Ratio 0.03x 1.20x 0.03x
Quick Ratio 0.02x 1.20x 0.00x

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -- -- -- -- -502.7% -288.9% -- --
Return on Assets (ROA) -539.8% -397.8% -483.3% -420.4% -204.2% -138.5% -265.9% -160.4%
Current Ratio 0.08x 0.18x 0.05x 0.03x 0.56x 1.03x 1.16x 1.20x
Quick Ratio 0.02x 0.01x 0.05x 0.02x -- 0.81x 0.84x 1.20x
Source: SEC EDGAR CompanyFacts (CIK 0001795091) · from March 31, 2023 Data through September 30, 2026 · synced Nov 21, 2026, 05:00 UTC · Open in terminal